Old Web
English
Sign In
Acemap
>
Paper
>
Tocilizumab in COVID-19 therapy: who benefits, and how?
Tocilizumab in COVID-19 therapy: who benefits, and how?
2021
Avidan U. Neumann
Mehmet Goekkaya
Karim Dorgham
Claudia Traidl-Hoffmann
Guy Gorochov
Keywords:
severe acute respiratory syndrome coronavirus 2
Virology
Coronavirus disease 2019
Tocilizumab
2019 20 coronavirus outbreak
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
1
Citations
NaN
KQI
[]